A. Ozkaya Et Al. , "Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes," JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4, pp.280-287, 2014
Ozkaya, A. Et Al. 2014. Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes. JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4 , 280-287.
Ozkaya, A., Alkin, Z., Osmanbasoglu, O. A., Ozkaya, H. M., & Demirok, A., (2014). Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes. JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4, 280-287.
Ozkaya, A. Et Al. "Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes," JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4, 280-287, 2014
Ozkaya, A. Et Al. "Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes." JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4, pp.280-287, 2014
Ozkaya, A. Et Al. (2014) . "Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes." JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.37, no.4, pp.280-287.
@article{article, author={A. Ozkaya Et Al. }, title={Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes}, journal={JOURNAL FRANCAIS D OPHTALMOLOGIE}, year=2014, pages={280-287} }